Celldex Therapeutics, Inc. Capital Expenditures
Celldex Therapeutics, Inc. (CLDX) reported Capital Expenditures of $4.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.18M, a 336.68% increase year-over-year.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.64M, a 518.49% increase year-over-year.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.28M, a 69.44% increase year-over-year.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $440.00K, a 19.27% decline year-over-year.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $2.71M, a 41.43% increase from fiscal 2024.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.92M, a 5.56% increase from fiscal 2023.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.82M, a 0.55% decline from fiscal 2022.
- Celldex Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.83M, a 46.36% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.82M 10-Q · filed 2026-08-06 | $6.10M derived: sum of 3 quarters · filed 2026-08-06 | $6.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.64M 10-Q · filed 2026-05-07 | $2.92M derived: sum of 2 quarters · filed 2026-05-07 | $3.36M derived: sum of 3 quarters · filed 2026-05-07 | $4.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.72M derived: sum of 2 quarters · filed 2026-02-25 | $2.45M derived: sum of 3 quarters · filed 2026-08-06 | $2.71M 10-K · filed 2026-02-25 |
| 2025-09-30 | $440.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.17M derived: sum of 2 quarters · filed 2026-08-06 | $1.43M 10-Q · filed 2025-11-10 | $2.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $993.00K 10-Q · filed 2026-08-06 | $1.75M derived: sum of 3 quarters · filed 2026-08-06 | $2.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $265.00K 10-Q · filed 2026-05-07 | $1.02M derived: sum of 2 quarters · filed 2026-05-07 | $1.57M derived: sum of 3 quarters · filed 2026-05-07 | $1.84M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.30M derived: sum of 2 quarters · filed 2026-02-25 | $1.57M derived: sum of 3 quarters · filed 2026-02-25 | $1.92M 10-K · filed 2026-02-25 |
| 2024-09-30 | $545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $819.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.16M 10-Q · filed 2025-11-10 | $1.83M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $618.00K 10-Q · filed 2025-08-07 | $1.28M derived: sum of 3 quarters · filed 2026-02-25 | $1.44M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $344.00K 10-Q · filed 2025-05-08 | $1.01M derived: sum of 2 quarters · filed 2026-02-25 | $1.17M derived: sum of 3 quarters · filed 2026-02-25 | $1.58M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $666.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $823.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.23M derived: sum of 3 quarters · filed 2026-02-25 | $1.82M 10-K · filed 2026-02-25 |
| 2023-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $567.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.15M 10-Q · filed 2024-11-06 | $1.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $410.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $995.00K 10-Q · filed 2024-08-08 | $1.23M derived: sum of 3 quarters · filed 2025-02-27 | $1.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $585.00K 10-Q · filed 2024-05-06 | $820.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.17M derived: sum of 3 quarters · filed 2025-02-27 | $1.84M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $580.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.25M derived: sum of 3 quarters · filed 2025-02-27 | $1.83M 10-K · filed 2025-02-27 |
| 2022-09-30 | $345.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.02M derived: sum of 2 quarters · filed 2023-11-02 | $1.59M 10-Q · filed 2023-11-02 | $1.95M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.25M 10-Q · filed 2023-08-08 | $1.60M derived: sum of 3 quarters · filed 2024-02-26 | $1.79M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $575.00K 10-Q · filed 2023-05-04 | $929.00K derived: sum of 2 quarters · filed 2024-02-26 | $1.11M derived: sum of 3 quarters · filed 2024-02-26 | $1.26M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $539.00K derived: sum of 2 quarters · filed 2024-02-26 | $682.00K derived: sum of 3 quarters · filed 2024-02-26 | $1.25M 10-K · filed 2024-02-26 |
| 2021-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $328.00K derived: sum of 2 quarters · filed 2022-11-09 | $895.00K 10-Q · filed 2022-11-09 | $1.14M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $710.00K 10-Q · filed 2022-08-08 | $957.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.12M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $567.00K 10-Q · filed 2022-05-05 | $814.00K derived: sum of 2 quarters · filed 2023-02-28 | $974.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.88M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $407.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.32M derived: sum of 3 quarters · filed 2023-02-28 | $1.55M 10-K · filed 2023-02-28 |
| 2020-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.07M derived: sum of 2 quarters · filed 2021-11-09 | $1.30M 10-Q · filed 2021-11-09 | $1.41M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $910.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.15M 10-Q · filed 2021-08-05 | $1.25M derived: sum of 3 quarters · filed 2022-02-28 | $1.39M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $235.00K 10-Q · filed 2021-05-06 | $340.00K derived: sum of 2 quarters · filed 2022-02-28 | $482.00K derived: sum of 3 quarters · filed 2022-02-28 | $780.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $247.00K derived: sum of 2 quarters · filed 2022-02-28 | $545.00K derived: sum of 3 quarters · filed 2022-02-28 | $731.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $440.00K derived: sum of 2 quarters · filed 2020-11-05 | $626.00K 10-Q · filed 2020-11-05 | $788.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $484.00K 10-Q · filed 2020-08-06 | $646.00K derived: sum of 3 quarters · filed 2021-03-29 | $706.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | $186.00K 10-Q · filed 2020-05-06 | $348.00K derived: sum of 2 quarters · filed 2021-03-29 | $408.00K derived: sum of 3 quarters · filed 2021-03-29 | $740.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $222.00K derived: sum of 2 quarters · filed 2021-03-29 | $554.00K derived: sum of 3 quarters · filed 2021-03-29 | $813.00K 10-K · filed 2021-03-29 |
| 2018-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $392.00K derived: sum of 2 quarters · filed 2019-11-12 | $651.00K 10-Q · filed 2019-11-12 | $841.00K derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $591.00K 10-Q · filed 2019-08-07 | $781.00K derived: sum of 3 quarters · filed 2020-03-26 | $1.06M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $259.00K 10-Q · filed 2019-05-07 | $449.00K derived: sum of 2 quarters · filed 2020-03-26 | $731.00K derived: sum of 3 quarters · filed 2020-03-26 | $1.67M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $472.00K derived: sum of 2 quarters · filed 2020-03-26 | $1.41M derived: sum of 3 quarters · filed 2020-03-26 | $1.79M 10-K · filed 2020-03-26 |
| 2017-09-30 | $282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.22M derived: sum of 2 quarters · filed 2018-11-07 | $1.60M 10-Q · filed 2018-11-07 | $2.24M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $942.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.32M 10-Q · filed 2018-08-08 | $1.95M derived: sum of 3 quarters · filed 2019-03-07 | $2.76M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $374.00K 10-Q · filed 2018-05-10 | $1.01M derived: sum of 2 quarters · filed 2019-03-07 | $1.82M derived: sum of 3 quarters · filed 2019-03-07 | $2.58M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.44M derived: sum of 2 quarters · filed 2019-03-07 | $2.21M derived: sum of 3 quarters · filed 2019-03-07 | $2.75M 10-K · filed 2019-03-07 |
| 2016-09-30 | $806.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.57M derived: sum of 2 quarters · filed 2017-11-07 | $2.11M 10-Q · filed 2017-11-07 | $2.52M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $767.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.31M 10-Q · filed 2017-08-08 | $1.71M derived: sum of 3 quarters · filed 2018-03-07 | $3.08M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $540.00K 10-Q · filed 2017-05-09 | $947.00K derived: sum of 2 quarters · filed 2018-03-07 | $2.31M derived: sum of 3 quarters · filed 2018-03-07 | $3.85M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $1.77M derived: sum of 2 quarters · filed 2018-03-07 | $3.31M derived: sum of 3 quarters · filed 2018-03-07 | $4.88M 10-K · filed 2018-03-07 |
| 2015-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.91M derived: sum of 2 quarters · filed 2016-11-07 | $4.47M 10-Q · filed 2016-11-07 | $4.63M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $3.11M 10-Q · filed 2016-08-08 | $3.27M derived: sum of 3 quarters · filed 2017-03-14 | $3.94M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $1.56M 10-Q · filed 2016-05-05 | $1.72M derived: sum of 2 quarters · filed 2017-03-14 | $2.40M derived: sum of 3 quarters · filed 2017-03-14 | $3.29M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $835.00K derived: sum of 2 quarters · filed 2017-03-14 | $1.73M derived: sum of 3 quarters · filed 2017-03-14 | $1.93M 10-K · filed 2017-03-14 |
| 2014-09-30 | $672.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.57M derived: sum of 2 quarters · filed 2015-11-05 | $1.77M 10-Q · filed 2015-11-05 | $4.08M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $899.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.09M 10-Q · filed 2015-08-10 | $3.41M derived: sum of 3 quarters · filed 2016-02-25 | $4.40M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $195.00K 10-Q · filed 2015-04-29 | $2.51M derived: sum of 2 quarters · filed 2016-02-25 | $3.50M derived: sum of 3 quarters · filed 2016-02-25 | $4.25M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $2.32M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $3.30M derived: sum of 2 quarters · filed 2016-02-25 | $4.06M derived: sum of 3 quarters · filed 2016-02-25 | $4.22M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $984.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $1.74M derived: sum of 2 quarters · filed 2014-11-05 | $1.90M 10-Q · filed 2014-11-05 | $2.01M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $755.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $917.00K 10-Q · filed 2014-08-07 | $1.03M derived: sum of 3 quarters · filed 2015-02-24 | $1.10M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $162.00K 10-Q · filed 2014-05-01 | $272.00K derived: sum of 2 quarters · filed 2015-02-24 | $343.00K derived: sum of 3 quarters · filed 2015-02-24 | $423.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $181.00K derived: sum of 2 quarters · filed 2015-02-24 | $261.00K derived: sum of 3 quarters · filed 2015-02-24 | $303.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $151.00K derived: sum of 2 quarters · filed 2013-11-08 | $193.00K 10-Q · filed 2013-11-08 | $299.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $122.00K 10-Q · filed 2013-08-06 | $228.00K derived: sum of 3 quarters · filed 2014-03-03 | $349.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $42.00K 10-Q · filed 2013-05-03 | $148.00K derived: sum of 2 quarters · filed 2014-03-03 | $269.00K derived: sum of 3 quarters · filed 2014-03-03 | $349.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $227.00K derived: sum of 2 quarters · filed 2014-03-03 | $307.00K derived: sum of 3 quarters · filed 2014-03-03 | $509.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $201.00K derived: sum of 2 quarters · filed 2012-11-02 | $403.00K 10-Q · filed 2012-11-02 | $841.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $282.00K 10-Q · filed 2012-08-09 | $720.00K derived: sum of 3 quarters · filed 2013-03-08 | $1.25M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $202.00K 10-Q · filed 2012-05-04 | $640.00K derived: sum of 2 quarters · filed 2013-03-08 | $1.17M derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | $438.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $971.00K derived: sum of 2 quarters · filed 2013-03-08 | $2.10M 10-K · filed 2013-03-08 | |
| 2010-09-30 | $533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $1.66M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $1.13M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $528.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |